Initiating SGLT2 inhibitor therapy to improve renal outcomes for persons with diabetes eligible for an intensified glucose-lowering regimen: hypothetical intervention using parametric g-formula modeling

INTRODUCTION: Sodium–glucose cotransporter 2 (SGLT2) inhibitors are now recommended in guidelines for persons with type 2 diabetes mellitus (T2DM) and at risk of advanced kidney disease as part of the glucose-lowering regimen. RESEARCH DESIGN AND METHODS: To explore the optimal threshold at which to...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Masato, Ogura, Masahito, Inagaki, Nobuya, Kawakami, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Epidemiology/Health services research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185419/
https://www.ncbi.nlm.nih.gov/pubmed/35675951
http://dx.doi.org/10.1136/bmjdrc-2021-002636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185419/
https://www.ncbi.nlm.nih.gov/pubmed/35675951
http://dx.doi.org/10.1136/bmjdrc-2021-002636

Ejemplares similares